Spatial patterns of dopamine transporter binding and multiple system atrophy subtypes

Takeaway

  • Spatial patterns of dopamine transporter (DAT) binding, as demonstrated by [18F]fluoro-propyl-carbomethoxy-iodophenyl-tropane ([18F]FP-CIT) positron emission tomography (PET), can reflect specific clinical features of multiple system atrophy (MSA).

Why this matters

  • It is thought that spatial patterns of neurodegeneration in striatal and extrastriatal regions may reflect various MSA clinical symptoms; however, this has not been clearly elucidated via in vivo studies, with MSA pathophysiology currently confirmed by autopsy.

  • The demonstration of DAT spatial patterns linked to clinical MSA phenotypes may have implications for targeted therapy development aimed at specific MSA subtypes; however, further study utilizing longitudinal and postmortem designs is required to validate this.

International Medical Press is a global provider of independent medical education. Its mission is to provide healthcare professionals with high-quality, trusted medical information with the aim of helping optimize patient care.

No responsibility is assumed by International Medical Press for any injury and/or damage to persons or property through negligence or otherwise, or from any use or operation of any methods, products, instructions, or ideas contained in the material herein. Because of rapid advances in the medical sciences, International Medical Press recommends that independent verification of diagnoses and drug dosages should be made. The opinions expressed do not reflect those of International Medical Press or the sponsor. International Medical Press assumes no liability for any material contained herein.